Literature DB >> 17075602

Diagnosis and treatment of vasculitis of the central nervous system in a patient with systemic lupus erythematosus.

Nikolay P Nikolov1, Janine A Smith, Nicholas J Patronas, Gabor G Illei.   

Abstract

BACKGROUND: A 23-year-old white woman with a 3-year history of systemic lupus erythematosus and a 15-month history of lupus nephritis and retinal vasculitis was successfully treated with antibiotics for Pseudomonas aeruginosa pneumonia while on moderate doses of corticosteroids. Even though her pneumonia had improved, she developed acute changes in her mental status that rapidly progressed to encephalopathy with coma. INVESTIGATIONS: Physical examination, fundoscopic examination, laboratory tests for metabolic abnormalities, cerebrospinal fluid analysis, microbiology and serologic testing, electroencephalogram, tests for IgM and IgG anticardiolipin antibodies, neuroimaging including CT of the brain and T1-weighted MRI before and after gadolinium contrast, and flow-attenuated inversion recovery MRI. DIAGNOSIS: Vasculitis of the central nervous system associated with systemic lupus erythematosus. MANAGEMENT: Intravenous methylprednisolone 1,000 mg/day for 3 days, one dose of intravenous pulse cyclophosphamide 750 mg/m(2), intravenous immunoglobulin 400 mg/kg/day for 4 days, plasmapheresis on alternate days for five cycles, and prednisone 40 mg/day. She continued monthly doses of intravenous pulse cyclophosphamide and intravenous pulse methylprednisolone for 6 months, followed by maintenance infusions every 3 months over 2 years. Prednisone was tapered over 18 months. Cyclophosphamide was discontinued after 2 years because of poor bone-marrow tolerance, and was replaced with mycophenolate mofetil 3,000 mg/ day and ciclosporin 50 mg twice daily.

Entities:  

Mesh:

Year:  2006        PMID: 17075602     DOI: 10.1038/ncprheum0337

Source DB:  PubMed          Journal:  Nat Clin Pract Rheumatol        ISSN: 1745-8382


  2 in total

1.  Posterior reversible encephalopathy syndrome in ANCA-associated vasculitis.

Authors:  Hong-Liang Zhang; Yi Yang; Jiang Wu
Journal:  Rheumatol Int       Date:  2011-07-15       Impact factor: 2.631

2.  Lymphocytic vasculitis involving the central nervous system occurs in patients with X-linked lymphoproliferative disease in the absence of Epstein-Barr virus infection.

Authors:  Kawsar R Talaat; Jennifer A Rothman; Jeffrey I Cohen; Mariarita Santi; John K Choi; Miguel Guzman; Robert Zimmerman; Sudha Nallasamy; Alexander Brucker; Martha Quezado; Stefania Pittaluga; Nicholas J Patronas; Amy D Klion; Kim E Nichols
Journal:  Pediatr Blood Cancer       Date:  2009-12       Impact factor: 3.167

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.